Cargando…
Polymorphism in COX-2 modifies the inverse association between Helicobacter pylori seropositivity and esophageal squamous cell carcinoma risk in Taiwan: a case control study
BACKGROUND: Overexpression of Cyclooxygenase-2 (COX-2) was observed in many types of cancers, including esophageal squamous cell carcinoma (ESCC). One functional SNP, COX-2 -1195G/A, has been reported to mediate susceptibility of ESCC in Chinese populations. In our previous study, the presence of He...
Autores principales: | Hu, Huang-Ming, Kuo, Chao-Hung, Lee, Chien-Hung, Wu, I-Chen, Lee, Ka-Wo, Lee, Jang-Ming, Goan, Yih-Gang, Chou, Shah-Hwa, Kao, Ein-Long, Wu, Ming-Tsang, Wu, Deng-Chyang |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2693118/ https://www.ncbi.nlm.nih.gov/pubmed/19463183 http://dx.doi.org/10.1186/1471-230X-9-37 |
Ejemplares similares
-
Trend of changes in antibiotic resistance in Helicobacter pylori from 2013 to 2019: a multicentre report from Taiwan
por: Liang, Chih-Ming, et al.
Publicado: (2020) -
Helicobacter pylori Infection
por: Hsu, Ping-I, et al.
Publicado: (2015) -
The Optimal First-Line Therapy of Helicobacter pylori Infection in Year 2012
por: Kuo, Chao-Hung, et al.
Publicado: (2012) -
Comparison of Second-Line Quadruple Therapies with or without Bismuth for Helicobacter pylori Infection
por: Jheng, Guang-Hong, et al.
Publicado: (2015) -
Helicobacter pylori Seropositivity and Risk of Lung Cancer
por: Koshiol, Jill, et al.
Publicado: (2012)